• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为什么参加心力衰竭临床试验的患者与我们在日常临床实践中见到的患者不一样?

Why are patients in clinical trials of heart failure not like those we see in everyday practice?

作者信息

Lloyd-Williams Ffion, Mair Frances, Shiels Christopher, Hanratty Barbara, Goldstein Pauline, Beaton Susan, Capewell Simon, Lye Michael, Mcdonald Ruth, Roberts Christopher, Connelly Derek

机构信息

Department of Primary Care, University of Liverpool, Whelan Building, 2nd Floor, Quadrangle Borwnlow Hill, L69 3DG, Liverpool, UK.

出版信息

J Clin Epidemiol. 2003 Dec;56(12):1157-62. doi: 10.1016/s0895-4356(03)00205-1.

DOI:10.1016/s0895-4356(03)00205-1
PMID:14680665
Abstract

BACKGROUND/OBJECTIVES: Evidence-based research has been criticized for not being relevant to the real world of patient care in the community, mainly because participants in research studies are dissimilar to those typically seen in every day practice. This article examines recruitment difficulties, and identifies the main reasons why patients with heart failure declined to participate in a research trial.

METHODS

Postal survey of potential trial participants (n=667), at time of recruitment. Analysis of (1) clinical and sociodemographic characteristics of respondents and nonrespondents to survey, and decliners and consenters to participation in a randomized controlled trial.

RESULTS

No significant differences were found between respondents and nonrespondents in respect to sociodemographic or clinical variables. Males (OR=1.58, CI=1.04-2.41), younger patients (OR=1.05, CI=1.03-1.08), and those prescribed an angiotensin converting enzyme (ACE) inhibitor (OR=1.68, CI=1.10-2.57) were significantly more likely to consent to participate. Main reasons for nonparticipation were perceptions of being too old, too unwell, or too busy.

CONCLUSIONS

Explanations of the purpose of research need to counter against perceptions among participants and clarify the benefits and disadvantages of participating in an intervention study when unwell. Study design should recognize that many elderly patients have busy lives and caring responsibilities. Financial support for participation should be considered.

摘要

背景/目的:循证研究因与社区患者护理的现实世界无关而受到批评,主要原因是研究参与者与日常实践中常见的参与者不同。本文探讨了招募困难,并确定了心力衰竭患者拒绝参与研究试验的主要原因。

方法

在招募时对潜在试验参与者(n = 667)进行邮寄调查。分析(1)调查的应答者和无应答者以及随机对照试验的拒绝者和同意者的临床和社会人口统计学特征。

结果

在社会人口统计学或临床变量方面,应答者和无应答者之间未发现显著差异。男性(OR = 1.58,CI = 1.04 - 2.41)、年轻患者(OR = 1.05,CI = 1.03 - 1.08)以及开具了血管紧张素转换酶(ACE)抑制剂的患者(OR = 1.68,CI = 1.10 - 2.57)同意参与的可能性显著更高。不参与的主要原因是认为自己年龄太大、身体太差或太忙。

结论

研究目的的解释需要消除参与者的顾虑,并在身体不适时阐明参与干预研究的利弊。研究设计应认识到许多老年患者生活忙碌且有护理责任。应考虑为参与提供经济支持。

相似文献

1
Why are patients in clinical trials of heart failure not like those we see in everyday practice?为什么参加心力衰竭临床试验的患者与我们在日常临床实践中见到的患者不一样?
J Clin Epidemiol. 2003 Dec;56(12):1157-62. doi: 10.1016/s0895-4356(03)00205-1.
2
Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure.慢性心力衰竭行为疗法随机临床试验的患者招募
BMC Med Res Methodol. 2004 Apr 17;4:8. doi: 10.1186/1471-2288-4-8.
3
Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.为什么患有尿路感染的患者参与或不参与临床试验?一项关于德国家庭医学的定性研究。
Ger Med Sci. 2015 Oct 14;13:Doc17. doi: 10.3205/000221. eCollection 2015.
4
Why patients decline participation in an intervention to reduce re-hospitalization through patient activation: whom are we missing?为何患者拒绝参与通过提高患者自我管理能力来减少再次住院的干预措施:我们遗漏了哪些人群?
Trials. 2019 Jan 25;20(1):82. doi: 10.1186/s13063-019-3187-9.
5
Refusal to participate in heart failure studies: do age and gender matter?拒绝参与心力衰竭研究:年龄和性别有影响吗?
J Clin Nurs. 2016 Apr;25(7-8):983-91. doi: 10.1111/jocn.13135. Epub 2016 Feb 23.
6
Recruitment and Reasons for Non-Participation in a Family-Coping-Orientated Palliative Home Care Trial (FamCope).一项以家庭应对为导向的姑息性家庭护理试验(FamCope)的招募情况及未参与原因
J Psychosoc Oncol. 2015;33(6):655-74. doi: 10.1080/07347332.2015.1082168.
7
Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors.老年心力衰竭患者死亡率的决定因素:血管紧张素转换酶抑制剂的作用
Arch Intern Med. 1998 Oct 12;158(18):2024-8. doi: 10.1001/archinte.158.18.2024.
8
Audio-visual presentation of information for informed consent for participation in clinical trials.用于参与临床试验知情同意的信息视听展示。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003717. doi: 10.1002/14651858.CD003717.pub2.
9
The challenges of recruiting cancer patient/caregiver dyads: informing randomized controlled trials.招募癌症患者/照护者二人组的挑战:为随机对照试验提供信息。
BMC Med Res Methodol. 2018 Nov 21;18(1):146. doi: 10.1186/s12874-018-0614-7.
10
Demographic and AIDS-related characteristics of consenters to a population-based HIV-survey: results from a pilot study in Arusha, Tanzania.基于人群的艾滋病毒调查同意参与者的人口统计学特征及与艾滋病相关的特征:坦桑尼亚阿鲁沙一项试点研究的结果
East Afr Med J. 1994 Aug;71(8):483-9.

引用本文的文献

1
Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys.改变心血管试验参与的面貌:超越中年白人男性。
CJC Open. 2021 Aug 8;3(12 Suppl):S1-S3. doi: 10.1016/j.cjco.2021.07.018. eCollection 2021 Dec.
2
A research tool for measuring non-participation of older people in research on digital health.一种用于测量老年人在数字健康研究中不参与情况的研究工具。
BMC Public Health. 2019 Nov 8;19(1):1487. doi: 10.1186/s12889-019-7830-x.
3
Response bias to a randomised controlled trial of a lifestyle intervention in people at high risk of cardiovascular disease: a cross-sectional analysis.
对心血管疾病高危人群进行生活方式干预的随机对照试验的反应偏倚:一项横断面分析。
BMC Public Health. 2018 Sep 4;18(1):1092. doi: 10.1186/s12889-018-5939-y.
4
Sex and cardiovascular disease status differences in attitudes and willingness to participate in clinical research studies/clinical trials.在参与临床研究/临床试验的态度和意愿方面存在性别及心血管疾病状况差异。
Trials. 2018 May 30;19(1):300. doi: 10.1186/s13063-018-2667-7.
5
Barriers and facilitators to patient and public engagement and recruitment to digital health interventions: protocol of a systematic review of qualitative studies.患者及公众参与和招募到数字健康干预措施的障碍与促进因素:一项定性研究的系统评价方案
BMJ Open. 2016 Sep 2;6(9):e010895. doi: 10.1136/bmjopen-2015-010895.
6
Lifetime costs of medical care after heart failure diagnosis.心力衰竭诊断后的终身医疗费用。
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):68-75. doi: 10.1161/CIRCOUTCOMES.110.957225. Epub 2010 Dec 7.
7
Age- and gender-specific risk of death after first hospitalization for heart failure.年龄和性别特异性心力衰竭首次住院后死亡风险。
BMC Public Health. 2010 Oct 22;10:637. doi: 10.1186/1471-2458-10-637.
8
The epistemology and ethics of chronic disease research: further lessons from ECMO.慢性病研究的认识论和伦理学:从 ECMO 中得到的更多教训。
Theor Med Bioeth. 2010 Apr;31(2):107-22. doi: 10.1007/s11017-010-9139-8.
9
Factors associated with non-participation and drop-out in a lifestyle intervention for workers with an elevated risk of cardiovascular disease.与心血管疾病高危人群生活方式干预不参与和脱落相关的因素。
Int J Behav Nutr Phys Act. 2009 Dec 1;6:80. doi: 10.1186/1479-5868-6-80.
10
Hospitalizations after heart failure diagnosis a community perspective.心力衰竭诊断后的住院情况:社区视角
J Am Coll Cardiol. 2009 Oct 27;54(18):1695-702. doi: 10.1016/j.jacc.2009.08.019.